Chi Li

Chi Li

Auto-generated profile, based on publicly available information

Chi Li

Department of Pharmacology and Toxicology, University of Louisville

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2011 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
XWXiaoli Wang
Xiaoli Wang
CEColins O. Eno
Colins O. Eno
BABrian J. Altman
Brian J. Altman
YZYanglong Zhu
Yanglong Zhu
GZGuoping Zhao
Guoping Zhao
CLChi Li
Chi Li
Changes in metabolic processes play a critical role in the survival or death of cells subjected to various stresses. In the present study, we have investigated the effects of ER (endoplasmic reticulum) stress on cellular metabolism. A major difficulty in studying metabolic responses to ER stress is that ER stress normally leads to apoptosis and metabolic changes observed in dying cells may be misleading. Therefore we have used IL-3 (interleukin 3)-dependent Bak−/−Bax−/− haemopoietic cells which do not die in the presence of the ER-stress-inducing drug tunicamycin. Tunicamycin-treated Bak−/−Bax−/− cells remain viable, but cease growth, arresting in G1-phase and undergoing autophagy in the absence of apoptosis. In these cells, we used NMR-based SIRM (stable isotope-resolved metabolomics) to determine the metabolic effects of tunicamycin. Glucose was found to be the major carbon source for energy production and anabolic metabolism. Following tunicamycin exposure, glucose uptake and lactate production are greatly reduced. Decreased 13C labelling in several cellular metabolites suggests that mitochondrial function in cells undergoing ER stress is compromised. Consistent with this, mitochondrial membrane potential, oxygen consumption and cellular ATP levels are much lower compared with untreated cells. Importantly, the effects of tunicamycin on cellular metabolic processes may be related to a reduction in cell-surface GLUT1 (glucose transporter 1) levels which, in turn, may reflect decreased Akt signalling. These results suggest that ER stress exerts profound effects on several central metabolic processes which may help to explain cell death arising from ER stress in normal cells.

1 April 2014 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
GZGuoping Zhao
Guoping Zhao
YZYanglong Zhu
Yanglong Zhu
CEColins O. Eno
Colins O. Eno
YLYanlong Liu
Yanlong Liu
LDLynn DeLeeuw
Lynn DeLeeuw
CLChi Li
Chi Li
The proapoptotic Bcl-2 protein Bax by itself is sufficient to initiate apoptosis in almost all apoptotic paradigms. Thus, compounds that can facilitate disruptive Bax insertion into mitochondrial membranes have potential as cancer therapeutics. In our study, we have identified small-molecule compounds predicted to associate with the Bax hydrophobic groove by a virtual-screen approach. Among these, one lead compound (compound 106) promotes Bax-dependent but not Bak-dependent apoptosis. Importantly, this compound alters Bax protein stability in vitro and promotes the insertion of Bax into mitochondria, leading to Bax-dependent permeabilization of the mitochondrial outer membrane. Furthermore, as a single agent, compound 106 inhibits the growth of transplanted tumors, probably by inducing apoptosis in tumors. Our study has revealed a compound that activates Bax and induces Bax-dependent apoptosis, which may lead to the development of new therapeutic agents for cancer.

18 June 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
HDHoward Donninger
Howard Donninger
CLChi Li
Chi Li
JEJohn W. Eaton
John W. Eaton
KYKavitha Yaddanapudi
Kavitha Yaddanapudi
The advent of cancer immunotherapy has revolutionized the field of cancer treatment and offers cancer patients new hope. Although this therapy has proved highly successful for some patients, its efficacy is not all encompassing and several cancer types do not respond. Cancer vaccines offer an alternate approach to promote anti-tumor immunity that differ in their mode of action from antibody-based therapies. Cancer vaccines serve to balance the equilibrium of the crosstalk between the tumor cells and the host immune system. Recent advances in understanding the nature of tumor-mediated tolerogenicity and antigen presentation has aided in the identification of tumor antigens that have the potential to enhance anti-tumor immunity. Cancer vaccines can either be prophylactic (preventative) or therapeutic (curative). An exciting option for therapeutic vaccines is the emergence of personalized vaccines, which are tailor-made and specific for tumor type and individual patient. This review summarizes the current standing of the most promising vaccine strategies with respect to their development and clinical efficacy. We also discuss prospects for future development of stem cell-based prophylactic vaccines.

21 November 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YZYanglong Zhu
Yanglong Zhu
JEJohn W. Eaton
John W. Eaton
CLChi Li
Chi Li
While the cytotoxic effects of titanium dioxide (TiO2) nanoparticles have been under intense investigation, the molecular mechanisms of this cytotoxicity remain unknown. Here we investigated the influence of oncogenic transformation and a major apoptotic signaling pathway on cellular responses to TiO2 nanoparticles. Isogenic wild-type (WT) and apoptosis-resistant (Bak−/−Bax−/−) cell lines with and without tumorigenic transformation were examined. TiO2 nanoparticles preferentially reduced viability of tumorigenic cells in a dose-dependent fashion compared with their untransformed counterparts. Importantly, the elevated cytotoxicity of TiO2 nanoparticles was independent of a major Bak/Bax-dependent apoptosis pathway. Because transformation does not affect cellular fluid-phase endocytosis or nanoparticle uptake, it is likely that the increased cytotoxicity in tumor cells is due to the interaction between TiO2 nanoparticles and the lysosomal compartment. Overall, our data indicate that TiO2 nanoparticles induce cytotoxicity preferentially in transformed cells independent of a major apoptotic signaling pathway.

1 July 2012 in Molecular Biology of the Cell
Verified
Journal Article
Open access
CEColins O. Eno
Colins O. Eno
EEEmily F. Eckenrode
Emily F. Eckenrode
KOKristen E. Olberding
Kristen E. Olberding
GZGuoping Zhao
Guoping Zhao
CWCarl White
Carl White
CLChi Li
Chi Li
Bcl-2 proteins are major regulators of cellular responses to intrinsic and extrinsic apoptotic stimuli. Among them, overexpression of the antiapoptotic protein Bcl-xLmodulates intracellular Ca2+homeostasis and organelle-specific apoptotic signaling pathways. However, the specific activities of Bcl-xLat mitochondria and the endoplasmic reticulum (ER) have not been fully defined. To further explore this, we generated mouse embryonic fibroblast (MEF) cell lines deficient in Bcl-xLexpression (Bcl-x-KO). Deficiency in Bcl-xLexpression did not induce compensatory changes in the expression of other Bcl-2 proteins, and Bcl-x-KO MEF cells showed increased sensitivity to various apoptotic stimuli compared with wild-type MEF cells. Targeting Bcl-xLat mitochondria but not at the ER restored apoptosis protection in Bcl-x-KO MEF cells to the degree observed in wild-type MEF cells. However, expression of ER-targeted Bcl-xLbut not mitochondrially targeted Bcl-xLwas required to restore Ca2+homeostasis in Bcl-x-KO MEF cells. Of importance, ER-targeted Bcl-xLwas able to protect cells against death stimuli in the presence of endogenous Bcl-xL. These data indicate that mitochondrial Bcl-xLcan regulate apoptosis independently of ER Bcl-xLand that when localized exclusively at the ER, Bcl-xLimpinges on Ca2+homeostasis but does not affect apoptosis unless Bcl-xLis present in additional cellular compartments.

22 December 2018 in OncoImmunology
Verified
Journal Article
Closed access
KYKavitha Yaddanapudi
Kavitha Yaddanapudi
SMShuhan Meng
Shuhan Meng
AWAaron G. Whitt
Aaron G. Whitt
NRNuman Al Rayyan
Numan Al Rayyan
JRJamaal Richie
Jamaal Richie
CLChi Li
Chi Li
The antigenic similarity between embryos and tumors has raised the idea of using embryonic material as a preventative vaccine against neoplastic disease. Indeed, we have previously reported that a vaccine comprises allogeneic murine embryonic stem cells (ESCs) and murine fibroblasts expressing GM-CSF (to amplify immune responses) successfully blocks the outgrowth of an implantable cancer (Lewis lung carcinoma; LLC) and lung tumors generated in mice using a combination of a mutagen followed by chronic pulmonary inflammation. However, such a vaccine is obviously impractical for application to humans. The use of fibroblasts to generate GM-CSF is needlessly complicated, and intact whole ESCs carry the hazard of generating embryomas/teratomas. Here, we report the successful application of an alternative prophylactic vaccine comprises exosomes derived from murine ESCs engineered to produce GM-CSF. Vaccination of mice with these exosomes significantly slowed or blocked the outgrowth of implanted LLC while control exosomes lacking GM-CSF were ineffective. Examination of tumor-infiltrating immune cells from mice vaccinated with the GM-CSF-expressing exosomes showed robust tumor-reactive CD8+ T effector responses, Th1 cytokine responses, and higher CD8+ T effector/CD4+CD25+Foxp3+ T regulatory cell ratio in the tumors. We conclude that a similar vaccine derived from GM-CSF- expressing human ESCs can be employed as a preventative vaccine for humans with an increased risk of developing cancer.